Chinese Shot Takes Controversial Path to Vaccinating the World
Bloomberg News, Bloomberg News
Weidong Yin
, Getty Images via Bloomberg
(Bloomberg) -- Indonesia, one of the first nations to bet its Covid-19 vaccination campaign on Sinovac Biotech Ltd., was about to announce a stunning development, one that would help vindicate a shot thatâs been shrouded in controversy for months. Over in Beijing, though, the companyâs chief executive officer was unaware.
A study of some 128,000 Jakarta health workers released Wednesday found Sinovacâs vaccine -- known as CoronaVac -- was far more protective than clinical trials had indicated. A day earlier, it wasnât mentioned by CEO Yin Weidong in a wide-ranging interview with Bloomberg reporters, and representatives later confirmed the company didnât know the announcement was coming.